Cellectar Biosciences, Inc. (CLRB)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | 8-K (2026-05-14) · 99.1 | ||
| 10-K/A | FY-2025 | |||
| 10-KLatest | FY-2025 | 8-K (2026-03-04) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-13) · 99.1 | 8-K (2025-10-10) | ||
| 10-Q | Q2-2025 | 8-K (2025-08-14) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-13) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-03-13) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-18) · 99.1 | ||
| 10-K/A | FY-2023 | |||
| 10-Q | Q2-2024 | 8-K (2024-08-13) · 99.1 | 8-K (2024-07-23) · 99.1 | ||
| 10-Q/A | Q1-2024 | |||
| 10-Q | Q1-2024 | 8-K (2024-05-14) · 99.1 | ||
| 10-K/A | FY-2022 | |||
| 10-K | FY-2023 | 8-K (2024-03-27) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-02) · 99.1 | ||
| 10-Q | Q2-2023 | 8-K (2023-08-14) · 99.1 | ||
| 10-K/A | FY-2022 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations | ||
| Consolidated Statements of Convertible Preferred Stock and Stockholders' (deficit) Equity | — |
|
| Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (deficit) | ||
| Consolidated Statements of Stockholders' (deficit) Equity | ||
| Consolidated Statements of Stockholders' Equity (deficit) | — |
|
| Consolidated Statements of Cash Flows | ||
| Notes | ||
| Accounts Payable and Accrued Liabilities | — |
|
| Award Timing Disclosure | — |
|
| Commitments and Contingencies | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Employee Retirement Plan | — |
|
| Fair Value | ||
| Fixed Assets | — |
|
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Leases | ||
| Nature of Business and Organization | ||
| Net Loss Per Share | ||
| Operating Segment | ||
| Pay Vs Performance Disclosure | ||
| Property, Plant & Equipment | — |
|
| Stock-based Compensation | ||
| Stockholders' Equity | ||
| Subsequent Event | ||
| Summary of Significant Accounting Policies | — |
|